Successful, we will reply to you quickly.OK
Please select the quantity.OK
Your message is being sent, please wait.Close
Send mail failed, please send again!Close
Products are for research use only. Not for human use. We do not sell to patients.
(Calpain inhibitor I; ALLN)
MG-101 Chemical Structure
|Product name: MG-101|
|Cat. No.: HY-18964|
MG-101 is a potent inhibitor of cysteine proteases including calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 500 pM).
IC50 value: 150 nM (Ki)
Target: cysteine protease
in vitro: MG-101 is a calpain inhibitor (IC50 = 0.09 μM) that activates p53-dependent apoptosis in tumor cell lines. At 10-100 μM MG-101 dose-dependently prevents the degradation of IκBα and IκBβ by the ubiquitin-proteasome complex, which blocks activation of NFκB and the production of TNF and IL-1β, suggesting a potential therapeutic effect for inflammatory diseases.2 At 10 μM, MG-101 can inhibit nitric oxide production by activated macrophages by interfering with transcription of the inducible nitric oxide synthase gene. In HCT116 cells, MG-101 decreases cell viability and tumor growth, and induces apoptosis response through Bax translocation from cytosol to mitochondria. 
in vivo: In mice bearing HCT116 xenografts, MG-101 (10 mg/kg i.p.) inhibits colon tumor formation. 
|M.Wt||383.53||Storage||Please store the product under the recommended conditions in the Certificate of Analysis.|
|Solvent & Solubility||
10 mM in DMSO
|1 mg||5 mg||10 mg|
|1 mM||2.6074 mL||13.0368 mL||26.0736 mL|
|5 mM||0.5215 mL||2.6074 mL||5.2147 mL|
|10 mM||0.2607 mL||1.3037 mL||2.6074 mL|
Bortezomib (PS-341) is a potent 20S proteasome inhibitor with Ki of 0.6 nM.
Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity.
Epoxomicin(BU-4061T) is a potent anti-tumor agent isolated from Actinomycetes that is used as a selective and irreversible inhibitor of the 20S proteasome.
Gabexate Mesylate is a Factor X inhibitor.
MLN2238(Ixazomib) inhibits the chymotrypsin-like proteolytic ((beta)5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM, respectively.
MLN9708 immediately hydrolyzed to MLN2238, which is an N-capped dipeptidyl leucine boronic acid and preferentially bound to and inhibited the 20S proteasome with an IC50 value of 3.4 nM (Ki = 0.93 nM).
ONX-0914 (PR-957) is a potent and selective immunoproteasome inhibitor with minimal cross-reactivity for the constitutive proteasome.
Oprozomib (ONX 0912; PR047) is an orally bioavailable inhibitor for CT-L activity of 20S proteasome (beta)5/LMP7 with IC50 of 36 nM/82 nM.
PD151746 is a calpain inhibitor, shows a 20-fold selectivity for u-calpain (Ki = 0.26 (plusmn) 0.03 (mu)M) over m-calpain (Ki = 5.33 (plusmn) 0.77 (mu)M).
PD 150606 is a selective, cell-permeable non-peptide calpain inhibitor (Ki values for (nu) and m-calpains are 0.21 and 0.37 (mu)M respectively).